Immunotherapy and cytokines

被引:9
|
作者
VanKampen, KR
机构
[1] Van Kampen Group, Inc., Ogden, UT
[2] Van Kampen Group, Inc., Ogden, UT 84405
关键词
D O I
10.1016/S1096-2867(97)80032-1
中图分类号
R61 [外科手术学];
学科分类号
摘要
Immunomodulation is now possible in veterinary medicine with the licensure of a number of biological products by the United States Department of Agriculture for veterinary use. These products activate primarily macrophages, induce the production of cytokines, and have various effects on the activity and proliferation of B and T lymphocytes. Those products most commonly used are inactivated whole bacteria of Propionibacterium acnes, cell wall fractions of nonpathogenic Mycobacterium spp, and the lysate derived from lysis of Staphylococcus aureus by a bacterial phage. All products have been licensed for use against specific diseases, but the literature includes studies for off-label usage. These immunomodulators are considered to be nonspecific stimulators of the immune system and may affect both humoral and cellular functions of immunity. Copyright © 1997 by W.B. Saunders Company.
引用
收藏
页码:186 / 192
页数:7
相关论文
共 50 条
  • [1] Cytokines in Cancer Immunotherapy
    Waldmann, Thomas A.
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2018, 10 (12): : 23
  • [2] CYTOKINES - A NEW IMMUNOTHERAPY
    CAIRO, MS
    CLINICS IN PERINATOLOGY, 1991, 18 (02) : 343 - 359
  • [3] Cytokines: Signalling Improved Immunotherapy?
    De Luca, Alana J.
    Lyons, A. Bruce
    Flies, Andrew S.
    CURRENT ONCOLOGY REPORTS, 2021, 23 (09)
  • [4] Targeted cytokines for cancer immunotherapy
    Holger N. Lode
    Ralph A. Reisfeld
    Immunologic Research, 2000, 21 : 279 - 288
  • [5] Cytokines in clinical cancer immunotherapy
    Pedro Berraondo
    Miguel F. Sanmamed
    María C Ochoa
    Iñaki Etxeberria
    Maria A. Aznar
    José Luis Pérez-Gracia
    María E. Rodríguez-Ruiz
    Mariano Ponz-Sarvise
    Eduardo Castañón
    Ignacio Melero
    British Journal of Cancer, 2019, 120 : 6 - 15
  • [6] Targeted cytokines for cancer immunotherapy
    Lode, HN
    Reisfeld, RA
    IMMUNOLOGIC RESEARCH, 2000, 21 (2-3) : 279 - 288
  • [7] Cytokines in cancer immunity and immunotherapy
    Smyth, MJ
    Cretney, E
    Kershaw, MH
    Hayakawa, Y
    IMMUNOLOGICAL REVIEWS, 2004, 202 : 275 - 293
  • [8] Cytokines in clinical cancer immunotherapy
    Berraondo, Pedro
    Sanmamed, Miguel F.
    Ochoa, Maria C.
    Etxeberria, Inaki
    Aznar, Maria A.
    Luis Perez-Gracia, Jose
    Rodriguez-Ruiz, Maria E.
    Ponz-Sarvise, Mariano
    Castanon, Eduardo
    Melero, Ignacio
    BRITISH JOURNAL OF CANCER, 2019, 120 (01) : 6 - 15
  • [9] Cytokines: Signalling Improved Immunotherapy?
    Alana J. De Luca
    A. Bruce Lyons
    Andrew S. Flies
    Current Oncology Reports, 2021, 23
  • [10] Biomarkers for Immunotherapy Toxicity: Are Cytokines the Answer?
    Johnson, Douglas B.
    Balko, Justin M.
    CLINICAL CANCER RESEARCH, 2019, 25 (05) : 1452 - 1454